CALL/TEVA PHARMACEUTICAL INDUSTRIES/24/1/21.03.25

CALL/TEVA PHARMACEUTICAL INDUSTRIES/24/1/21.03.25 Share Price

DE000GG79ET5

Market Closed - BOERSE MUENCHEN 11:55:46 31/05/2024 pm IST
0.57 ^EUR	-0.70%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart CALL/TEVA PHARMACEUTICAL INDUSTRIES/24/1/21.03.25

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)	01/06	BU
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024	01/06	BU
Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill	30/05	MT
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)	30/05	BU

More news

Quotes 5-day view

Date	Price	Change
31/24/31	0.57	-0.70%
30/24/30	0.574	+9.54%
29/24/29	0.524	-4.03%
28/24/28	0.546	+7.91%
27/24/27	0.506	-8.83%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 11:55 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Goldman Sachs
WKN	GG79ET
ISIN	DE000GG79ET5
Date issued	30/04/2024
Strike	24 $
Maturity	21/03/2025 (292 Days)
Parity	1 : 1
Emission price	0.32 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.64 €
Lowest since issue	0.247 €
Spread	0.03 €
Spread %	4.92%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.93 USD

Average target price

17.84 USD

Spread / Average Target

+5.35%

Consensus